U.S. could reach 100,000 new daily coronavirus cases if surge continues, Fauci says

Dr. Anthony Fauci said coronavirus cases could grow to 100,000 a day in the United States if Americans don't start following public health recommendations.

Comment by infectious disease expert comes as over 30 states report rising numbers of infections

Dr. Anthony Fauci, left, director of the U.S. National Institute of Allergy and Infectious Diseases, is pictured among experts testifying before a Senate committee hearing on Capitol Hill in Washington on Tuesday. (Kevin Dietsch/Pool/The Associated Press)

The United States is "going in the wrong direction" with the coronavirus surging badly enough that Dr. Anthony Fauci told senators Tuesday some regions are putting the entire country at risk — just as schools and colleges are wrestling with how to safely reopen.

With about 40,000 new cases being reported a day, Fauci, the federal government's top infectious disease expert, said he "would not be surprised if we go up to 100,000 a day if this does not turn around."

"I am very concerned," he told a hearing of the Senate health, education, labour and pensions committee.

Infections are rising rapidly, mostly in parts of the West and South, and Fauci and other public health experts said Americans everywhere will have to start following key recommendations if they want to get back to more normal activities like going to school.

"We've got to get the message out that we are all in this together," by wearing masks in public and keeping out of crowds, said Fauci, infectious disease chief at the National Institutes of Health (NIH).

Connect the dots, he told senators: When and how school buildings can reopen will vary depending on how widely the coronavirus is spreading locally.

"I feel very strongly we need to do whatever we can to get the children back to school," he said.

WATCH | Fauci warns U.S. could hit 100,000 daily coronavirus infections:

Dr. Fauci warns U.S. could hit up to 100,000 daily coronavirus infections

The National

11 months ago
The United States' top infectious disease expert, Dr. Anthony Fauci, is warning the COVID-19 caseload could hit up to 100,000 new daily infections if Americans don't change their behaviour. 2:00

The Centers for Disease Control and Prevention (CDC) plans more guidelines for local school systems, Director Robert Redfield said.

But in recommendations for colleges released Tuesday, the agency said it won't recommend entry testing for all returning students, faculty and staff. It's not clear if that kind of broad-stroke testing would reduce spread of the coronavirus, CDC concluded. Instead, it urged colleges to focus on containing outbreaks and exposures as students return.

Race for vaccine

Lawmakers also pressed for what Senator Patty Murray of Washington, the committee's top Democrat, called a national vaccine plan — to be sure the race for the COVID-19 vaccine ends with shots that really are safe, truly protect and are available to all Americans who want one.

"We can't take for granted this process will be free of political influence," Murray said. She cited how President Donald Trump promoted a malaria drug as a COVID-19 treatment that ultimately was found to be risky and ineffective.

A scientist examines coronavirus-infected cells under a microscope during research for a vaccine against COVID19 at a laboratory of BIOCAD biotechnology company in St. Petersburg, Russia, on May 20. (Anton Vaganov/Reuters)

The Food and Drug Administration (FDA) released guidelines Tuesday saying any vaccine that wins approval will have to be at least 50 per cent more effective than a dummy shot in the final required testing. That's less effective than many of today's vaccines, but independent experts say that would be a good start against the virus.

FDA commissioner Stephen Hahn said vaccine makers also must test their shots in diverse populations, including minorities, the elderly, pregnant women and those with chronic health problems.

"We will not cut corners in our decision-making," Hahn told senators.

About 15 vaccine candidates are in various stages of human testing worldwide, but the largest studies — each including 30,000 people — needed to prove whether a shot really protects are set to begin in July. First up is expected to be a vaccine created by the NIH and American biotech company Moderna Inc., followed closely by an Oxford University candidate.

At the same time, the Trump administration's "Operation Warp Speed" aims to stockpile hundreds of millions of doses by year's end so they could rapidly start vaccinations if and when one is proven to work.

Redfield said the CDC already is planning how to prioritize who is first in line for the scarce first doses and how they'll be distributed.

'Stakes are too high'

But a vaccine is at the very least many months away. For now, the committee's leading Republican stressed wearing a mask — and said Trump, who notoriously shuns them, needs to start because politics is getting in the way of protecting the American people.

"The stakes are too high for the political debate about pro-Trump, anti-Trump masks to continue," said Senator Lamar Alexander of Tennessee, who chaired Tuesday's hearing.

Alexander said he had to self-quarantine after a staff member tested positive for the virus but that he personally was protected because his staffer was wearing a mask.

"The president has plenty of admirers. They would follow his lead," Alexander said. 

Add some “good” to your morning and evening.

A variety of newsletters you'll love, delivered straight to you.

Sign up now


To encourage thoughtful and respectful conversations, first and last names will appear with each submission to CBC/Radio-Canada's online communities (except in children and youth-oriented communities). Pseudonyms will no longer be permitted.

By submitting a comment, you accept that CBC has the right to reproduce and publish that comment in whole or in part, in any manner CBC chooses. Please note that CBC does not endorse the opinions expressed in comments. Comments on this story are moderated according to our Submission Guidelines. Comments are welcome while open. We reserve the right to close comments at any time.

Become a CBC Member

Join the conversationCreate account

Already have an account?